1611 ET - Altria's current valuation is too high given the company has been offsetting cigarette volume declines through pricing, UBS analysts say in a research note. The maker of Marlboro cigarettes' combination of double digit cigarette volume declines and limited progress in smoke-free means Altria's net income could decline in FY26 and FY27, the analysts say, noting that their EPS estimates are 4.4% and 7.5% below consensus. Overall, the analysts project cigarette shipments to decline 13% in the first quarter, including a 160 basis points share loss that would result in smokeable net sales being down 2.9%. Shares fell 2% to $58.79. (sabela.ojea@wsj.com; @sabelaojeaguix)
(END) Dow Jones Newswires
April 01, 2025 16:11 ET (20:11 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。